速递|13亿美元!礼来拿下英伟达投资AI发现的新口服减肥药

GLP1减重宝典
Aug 17, 2025

整理 | GLP1减重宝典内容团队礼来公司(LLY.N)与私人持有的Superluminal Medicines达成一项价值13亿美元的合作协议,利用人工智能发现并开发用于治疗肥胖和其他心脏代谢疾病的小分子药物。礼来目前在快速增长的肥胖治疗市场中占据主导地位,该市场预计到下一个十年将达到1500亿美元。公司正通过研发新一代药物、收购以及合作来进一步扩大影响力。根据协议,礼来将获得独家权利,开发和...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10